Cavernous malformation (cavernoma, cavernous hemangioma) is a low-flow, angiographically occult vascular malformation composed of thin-walled, endothelium-lined sinusoidal vascular channels. It contains no intervening normal brain parenchyma. The most characteristic MRI finding is the 'popcorn' appearance on T2 and hemosiderin ring. Prominent blooming on SWI is the most sensitive diagnostic finding. It constitutes 5-13% of all cerebral vascular malformations. It may be sporadic (single) or familial (multiple — CCM1/CCM2/CCM3 mutations). It shows 20-30% association with developmental venous anomaly (DVA).
Age Range
20-60
Peak Age
35
Gender
Equal
Prevalence
Uncommon
Cavernous malformation consists of a compact cluster of thin endothelium-lined, low-flow sinusoidal vascular channels lacking an adventitial layer. These thin-walled channels are not separated by normal brain parenchyma (unlike AVM) and contain no intervening neural tissue. Thin, structurally weak vessel walls are prone to recurrent microhemorrhages; these hemorrhagic events create hemosiderin deposition around the lesion — forming the basis of the pathognomonic hemosiderin ring on MRI. The internal structure of the cavernoma contains blood products at different stages (oxyhemoglobin, deoxyhemoglobin, methemoglobin, hemosiderin), and this multi-layered structure creates the 'popcorn' appearance on T2. The prominent blooming on SWI results from the strong paramagnetic effect of hemosiderin and deoxyhemoglobin. The association with developmental venous anomaly (DVA) points to a common venous drainage pathology — DVA represents a congenital anomaly in draining venous structures, while cavernoma is a secondary vascular malformation developing in this area of abnormal venous drainage.
Mixed signal intensities from blood products at different stages on T2 ('popcorn' appearance) + complete hemosiderin ring surrounding the lesion + prominent blooming on SWI form a pathognomonic triad for cavernous malformation. Absence of perilesional edema supports this triad and provides additional diagnostic value for differentiation from tumoral lesions (hemorrhagic metastasis, glioblastoma). DVA association strengthens the diagnosis.
On non-contrast CT, cavernous malformation generally appears as a hyperdense or mixed-density lesion — hyperdensity reflects calcification and chronic blood products. No significant edema in surrounding parenchyma (except in acute hemorrhage). Small cavernomas may not be detectable on CT. In acute hemorrhage, markedly hyperdense area and surrounding edema may be visible. Calcification is seen in 40-60% of cases. CT is significantly inferior to MRI for cavernoma diagnosis — detection rate is much higher with SWI/GRE.
Report Sentence
On CT, a hyperdense/calcified lesion is identified without significant surrounding edema.
On T1-weighted images, cavernous malformation shows heterogeneous signal. Subacute blood (methemoglobin) creates hyperintense, acute blood (deoxyhemoglobin) isointense, and chronic hemosiderin hypointense signal. T1 hyperintense foci indicate the lesion's hemorrhagic history and active/subacute hemorrhage status. Peripheral hemosiderin ring may also be seen as hypointense on T1 but is much more prominent on T2 and SWI.
Report Sentence
On T1-weighted sequence, the lesion shows heterogeneous signal containing hyperintense foci consistent with subacute hemorrhage.
The most characteristic finding of cavernous malformation on T2-weighted images is the 'popcorn' appearance: mixed hyperintense and hypointense signal areas from blood products at different stages coexist in the lesion center. A complete, smooth, markedly hypointense hemosiderin ring surrounding the lesion is pathognomonic — called the 'dark rim'. Perilesional edema is generally absent (except during acute hemorrhage). Hemosiderin ring thickness increases with the number of recurrent hemorrhages. Multiple lesions suggest familial cavernomatosis.
Report Sentence
On T2-weighted sequence, the lesion shows mixed signal intensities reflecting blood products at different stages ('popcorn' appearance) with a complete low-signal hemosiderin ring surrounding the lesion.
On FLAIR, cavernous malformation shows heterogeneous signal. Methemoglobin areas are hyperintense, hemosiderin shows low signal. In acute hemorrhage, perilesional edema may be seen as markedly hyperintense on FLAIR. In chronic, stable cavernomas, surrounding edema is generally absent — this feature is valuable for differentiation from tumors. FLAIR shows the hemosiderin ring as well as T2 but is not as sensitive as SWI.
Report Sentence
On FLAIR, the lesion shows heterogeneous signal without significant perilesional edema.
On DWI, cavernous malformation shows no true diffusion restriction. T2* effect of blood products may create low signal on DWI ('susceptibility artifact' — blooming). Areas containing methemoglobin may show mildly elevated signal on DWI due to T1 shine-through, but no restriction on ADC map. Transient restriction may be seen in cytotoxic edema areas during acute hemorrhage. DWI is helpful in differentiating cavernoma from high-cellularity tumors (lymphoma) and abscess.
Report Sentence
On DWI, the lesion shows no true diffusion restriction with variable signal related to susceptibility artifact from blood products.
SWI (susceptibility weighted imaging) is the most sensitive sequence for cavernous malformation diagnosis. The strong paramagnetic effect of hemosiderin and deoxyhemoglobin creates marked blooming on SWI (signal loss — lesion appearing much larger than actual size). SWI detects even small type IV (Zabramski) cavernomas not visible on conventional T1/T2 sequences and is therefore the gold standard for familial cavernomatosis screening. DVA (developmental venous anomaly) association is visualized on SWI as converging veins in caput medusae pattern. Detection of multiple blooming foci on SWI strengthens suspicion of familial cavernomatosis (CCM1/CCM2/CCM3 mutations).
Report Sentence
On SWI, the lesion shows marked blooming artifact with strong susceptibility effect of hemosiderin deposition, which is pathognomonic for cavernous malformation.
On contrast-enhanced MRI, cavernous malformation generally shows minimal or no enhancement. Low-flow sinusoidal channels may show mild enhancement due to slow gadolinium distribution. Prominent or homogeneous enhancement is atypical for cavernoma and should suggest alternative diagnoses. Associated DVA (developmental venous anomaly) shows prominent enhancement — visualized as converging veins and central collector vein in 'caput medusae' pattern. The contrast between DVA enhancement and cavernoma non-enhancement confirms their association.
Report Sentence
On contrast sequence, the cavernous malformation shows minimal enhancement with an adjacent enhancing developmental venous anomaly (DVA) in caput medusae pattern.
Criteria
T1 hyperintense center (methemoglobin), T2 hyper or hypointense center + hypointense rim. Reflects subacute hemorrhage status. Clinically, symptoms may have recently occurred.
Distinct Features
Active hemorrhage — requires neurological evaluation and follow-up. Differentiated from other T1-hyperintense lesions (melanoma metastasis, lipoma) by hemosiderin ring.
Criteria
Most common type. Mixed signal intensity on T2 ('popcorn') + complete hemosiderin ring. Heterogeneous on T1. Contains hemorrhagic products of different ages. Typical diagnostic appearance.
Distinct Features
Pathognomonic appearance — diagnosis is generally made with Type II findings. Surgical decision depends on symptom status and location.
Criteria
Iso- to hypointense on T1 and T2, prominent blooming on GRE/SWI. Predominantly contains hemosiderin. Reflects chronic, stable hemorrhagic products.
Distinct Features
May not be prominent on T1/T2 — SWI is critical for diagnosis. Lower risk of symptom development in chronic lesions. Tends to remain stable on follow-up.
Criteria
Not visible on conventional T1/T2, only detected as small punctate blooming focus on GRE/SWI. Commonly seen in familial cavernomatosis. Diameter generally <5 mm.
Distinct Features
Cannot be diagnosed without SWI screening. SWI is mandatory in familial cavernomatosis screening. Clinical significance is generally low but numbers may increase over time.
Distinguishing Feature
Hemorrhagic metastasis (melanoma, renal, thyroid) can be confused with cavernoma, but metastasis has prominent perilesional edema, enhancement, and known primary malignancy history. Cavernoma has no or minimal edema, minimal enhancement, and no malignancy history.
Distinguishing Feature
AVM is a high-flow vascular malformation showing prominent flow voids on T2/SWI, visible feeding arteries on angiography, and early venous return. Cavernoma is low-flow, angiographically occult (invisible), and contains no flow voids. Hemosiderin ring is not typical in AVM.
Distinguishing Feature
Hemorrhagic glioblastoma can be confused with cavernoma, but glioblastoma has prominent perilesional edema, heterogeneous enhancement (ring pattern), high rCBV, and DWI restriction. These findings are absent or minimal in cavernoma.
Distinguishing Feature
Acute infarct with hemorrhagic transformation may show blooming on SWI, but infarct is located in vascular distribution territory, has marked DWI restriction, no 'popcorn' appearance on T2, and has acute neurological onset history.
Urgency
variable — asymptomatic observation, symptomatic semi-urgentManagement
observation for asymptomatic; surgical resection for symptomatic/hemorrhagicBiopsy
Not NeededFollow-up
Annual MRI for known cavernomas; immediate MRI for new symptoms; genetic testing for familial casesMost cavernous malformations are asymptomatic and incidentally detected, with annual MRI follow-up being sufficient. Annual hemorrhage risk is reported as 0.7-1.1% (sporadic) or 2.4-6.0% (prior hemorrhage). Surgical indications: recurrent symptomatic hemorrhage, intractable epilepsy (antiepileptic-resistant), progressive neurological deficit, and surgically accessible location. Stereotactic radiosurgery may be an alternative for brainstem cavernomas (high surgical risk). In familial cavernomatosis (multiple lesions), genetic testing (CCM1/CCM2/CCM3) and family screening is recommended. Preservation of DVA during surgery is mandatory — DVA resection may lead to venous infarction.
Cavernomas may present with seizures, hemorrhage, and focal neurological deficits. Annual hemorrhage risk is 0.5-1% (increases after prior hemorrhage). Surgical resection is considered for symptomatic or recurrent hemorrhagic lesions. Familial cavernomatosis (CCM1/2/3 mutations) presents with multiple lesions.